Acadia Healthcare Co Inc has a consensus price target of $85.2, established from looking at the 50 latest analyst ratings. The last 3 analyst ratings were released from Mizuho, Barclays, and Cantor Fitzgerald on March 6, 2024, March 6, 2024, and March 5, 2024. With an average price target of $91.33 between Mizuho, Barclays, and Cantor Fitzgerald, there's an implied 28.30% upside for Acadia Healthcare Co Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/06/2024 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 17.99% | Mizuho | Ann Hynes | $77 → $84 | Maintains | Neutral | Get Alert |
03/06/2024 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 40.47% | Barclays | Andrew Mok | → $100 | Initiates | → Overweight | Get Alert |
03/05/2024 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 26.42% | Cantor Fitzgerald | Sarah James | → $90 | Reiterates | Neutral → Neutral | Get Alert |
03/04/2024 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 32.04% | RBC Capital | Ben Hendrix | → $94 | Reiterates | Outperform → Outperform | Get Alert |
03/01/2024 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 41.87% | TD Cowen | Gary Taylor | $86 → $101 | Maintains | Outperform | Get Alert |
02/28/2024 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 43.28% | UBS | Andrew Mok | $88 → $102 | Maintains | Buy | Get Alert |
01/05/2024 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 29.23% | Stephens & Co. | Scott Fidel | → $92 | Upgrade | Equal-Weight → Overweight | Get Alert |
11/07/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 32.04% | RBC Capital | Ben Hendrix | $99 → $94 | Maintains | Outperform | Get Alert |
09/14/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 19.4% | Cantor Fitzgerald | Joseph France | $83 → $85 | Maintains | Neutral | Get Alert |
07/31/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 39.06% | RBC Capital | Ben Hendrix | $93 → $99 | Maintains | Outperform | Get Alert |
07/31/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 33.45% | Credit Suisse | A.J. Rice | → $95 | Reiterates | Outperform → Outperform | Get Alert |
07/12/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 16.59% | Stephens & Co. | Scott Fidel | → $83 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
06/02/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 16.59% | Stephens & Co. | Scott Fidel | → $83 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
05/04/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 33.45% | Credit Suisse | A.J. Rice | $93 → $95 | Maintains | Outperform | Get Alert |
04/28/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 33.45% | Credit Suisse | Jonathan Yong | $93 → $95 | Maintains | Outperform | Get Alert |
04/27/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 23.61% | Stephens & Co. | Scott Fidel | → $88 | Reiterates | → Equal-Weight | Get Alert |
04/24/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 29.23% | UBS | Andrew Mok | $96 → $92 | Maintains | Buy | Get Alert |
04/20/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | -11.5% | Deutsche Bank | Pito Chickering | $75 → $63 | Downgrade | Hold → Sell | Get Alert |
03/06/2023 | ACHC | Buy Now | Acadia Healthcare Co | $71.19 | 5.35% | Deutsche Bank | Pito Chickering | $82 → $75 | Maintains | Hold | Get Alert |
The latest price target for Acadia Healthcare Co (NASDAQ: ACHC) was reported by Mizuho on March 6, 2024. The analyst firm set a price target for $84.00 expecting ACHC to rise to within 12 months (a possible 17.99% upside). 16 analyst firms have reported ratings in the last year.
The latest analyst rating for Acadia Healthcare Co (NASDAQ: ACHC) was provided by Mizuho, and Acadia Healthcare Co maintained their neutral rating.
The last upgrade for Acadia Healthcare Co Inc happened on January 5, 2024 when Stephens & Co. raised their price target to $92. Stephens & Co. previously had an equal-weight for Acadia Healthcare Co Inc.
The last downgrade for Acadia Healthcare Co Inc happened on April 20, 2023 when Deutsche Bank changed their price target from $75 to $63 for Acadia Healthcare Co Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acadia Healthcare Co, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acadia Healthcare Co was filed on March 6, 2024 so you should expect the next rating to be made available sometime around March 6, 2025.
While ratings are subjective and will change, the latest Acadia Healthcare Co (ACHC) rating was a maintained with a price target of $77.00 to $84.00. The current price Acadia Healthcare Co (ACHC) is trading at is $71.19, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.